Indo Us Bio-Tech Limited reported earnings results for the fourth quarter ended March 31, 2024. For the fourth quarter, the company reported sales was INR 157.66 million compared to INR 181.1 million a year ago. Revenue was INR 159.77 million compared to INR 181.27 million a year ago.

Net income was INR 5.24 million compared to INR 27.72 million a year ago. Basic earnings per share from continuing operations was INR 0.26 compared to INR 2.76 a year ago. Diluted earnings per share from continuing operations was INR 0.26 compared to INR 2.76 a year ago.